The findings by Kim et al. [134] demonstrate that MALAT1 is a metastasis-suppressing lncRNA rather than a metastasis promoter in breast cancer, raising caution about targeting MALAT1 as an antimetastatic strategy. This evidence concerns the gene MALAT1 and breast cancer.